Stay updated on Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays Revision: v3.3.2 instead of v3.3.1; this appears to be a minor version label change without impacting study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedAdded Revision: v3.3.1 and removed Revision: v3.2.0 from the history.SummaryDifference0.1%

- Check29 days agoChange DetectedThe funding status notice about a lapse in government funding and related operating information has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedA new version entry was added to the record history. It introduces the IPDSharing section and expands the metadata fields shown (e.g., Study Status, Study Description, and Outcome Measures).SummaryDifference0.1%

- Check57 days agoChange DetectedAdds a new study date and a structured set of study-related sections, while removing an older date.SummaryDifference2%

- Check71 days agoChange Detected- Added a government funding notice about potential delays and current operating status, plus a link to cc.nih.gov and opm.gov for updates. - Bumped version from v3.1.0 to v3.2.0.SummaryDifference10%

Stay in the know with updates to Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial page.